Nalge Nunc to Distribute Molecular Cytomics Cellular Array Tech; May Have Hand in Next-Gen Products | GenomeWeb

Molecular Cytomics and Nalge Nunc have signed an exclusive agreement in which Nalge Nunc will distribute Molecular Cytomics' Optical LiveCell Array high-content analysis tool worldwide, CBA News learned this week.

According to officials from both companies, the two firms had been hammering out a possible partnership since last year, and finally signed an agreement last week. As a result, the Optical LiveCell Array could become a Nunc-branded product by as early as this summer, officials said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.